about
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaCefepime versus other beta-lactam antibiotics for the treatment of infections in non-neutropenic patientsCefepime versus other beta-lactam antibiotics for the treatment of infections in non-neutropenic patientsHorizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.Some Pharmacodynamic Aspects of Cefepime.Current guidelines for the treatment of severe pneumonia and sepsis.Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials.Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa.Elderly patients with community-acquired pneumonia: optimal treatment strategies.Increased cefepime MIC for enterobacteriacae clinical isolates.Therapeutic drug monitoring of cefepime with micellar electrokinetic capillary chromatography: Assay improvement, quality assurance, and impact on patient drug levels.Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?Monitoring of cefepime in human serum and plasma by micellar electrokinetic capillary chromatography: Improvement of sample preparation and validation by liquid chromatography coupled to mass spectrometry.An MEKC assay for the therapeutic drug monitoring of cefepime.Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.The pharmacokinetics change of cefepime after Shuanghuanglian injection administration in subjects with the renal damage.
P2860
Q22241905-41873A0B-DDC1-4263-9740-10A65CF1A8F5Q24200940-666610C6-60E8-4F78-B968-F7B4BDA812E0Q24242482-7782190F-5D32-4622-A73D-7A9E422DE536Q34352060-39F3C3AF-B1D9-4422-8821-D78C9FA23784Q35966554-96A07765-5821-4E59-851C-EFE4C687663BQ36129540-20084809-911F-4241-A0AF-053CDC7CE6C8Q36231604-728CABC2-9E9E-47AA-87D8-9546AB1D9CB0Q37121661-EF5FEFFB-E241-4AA7-937E-790635CDDB5AQ37538678-FD345882-EC25-42EB-8F27-A1B01D8D3C34Q37896600-45C9723F-6183-4F16-9C71-3D08AEC011E4Q39291589-B01CED06-D3F6-40AE-A817-4D961AD56EBCQ39808704-24A063E9-1D07-4060-9B5A-613084A67DADQ40047150-4B6A3A06-711F-4417-9354-95676829957FQ40325696-B9D124E7-D9A6-48D1-A742-A284991A84EDQ42254941-D8AA080D-6B81-4151-A899-D4A5CF157AD9Q51753731-DB95E3E1-13C1-4466-BA14-920FA6446A91Q53455227-44983567-CC7E-41D5-A494-50A7617B37CB
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cefepime
@ast
Cefepime
@en
type
label
Cefepime
@ast
Cefepime
@en
prefLabel
Cefepime
@ast
Cefepime
@en
P2860
P3181
P356
P1476
Cefepime
@en
P2093
Caroline M. Perry
Therese M. Chapman
P2860
P2888
P304
P3181
P356
10.1007/BF03256641
P577
2003-02-01T00:00:00Z
P6179
1008869543